TOP HEADLINES

FEATURED STORY

Covance pools its early-stage R&D services into one offering

Drug developers commonly deal with a host of CROs as they work their way from preclinical testing to first-in-human trials, a process designed to maximize the strengths of each contractor. But a piecemeal approach to early-stage development can lead to costly delays, according to Covance, which is pitching an all-encompassing offering it claims can seamlessly shuttle molecules from animal studies to Phase II.

PPD beefs up its Irish outpost with a new biologics lab

PPD has amped up the biologics capabilities at its Irish manufacturing operation, opening a new lab devoted to the development of large-molecule treatments.

Australian CRO Novotech firms up its Hong Kong presence

Australia's Novotech has made a permanent home in Hong Kong, ditching its old office in favor of a larger space as it works to capitalize on the growing demand for clinical services in the region.

Trial tech outfit goBalto bags $12M to expand around the world

San Francisco's goBalto raised $12 million to push its clinical trial software, designed to expedite study startup.

Parexel moves to pick up laid-off GlaxoSmithKline workers

Parexel is leasing a North Carolina building from GlaxoSmithKline, part of a deal between the two in which the CRO will absorb some researchers on the way out as the drugmaker mounts a major restructuring.

MORE NEWS

From Our Sister Sites

FiercePharma Manufacturing

A loose hair has contributed to the nationwide shortage of saline solution, as Hospira recalls another lot of the commonly used product.

FiercePharma

The ripple effects from last week's Teva v. Sandoz ruling have begun. The U.S. Supreme Court sent three patent fights back to a lower court in light of that ruling, which ordered the Federal Circuit Court to defer to district-level findings on patent claims unless a "clear error" had been made.